Antidiabetics Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Published By: Syndicate <strong>Market</strong> Research<br />
<strong>Antidiabetics</strong> <strong>Market</strong> Volume<br />
Forecast and Value Chain Analysis<br />
2014-2020<br />
Joel John<br />
3422 SW 15 Street, Suit #8138,<br />
Deerfield Beach,<br />
Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
Toll Free: 1-855-465-4651<br />
sales@Syndicate<strong>Market</strong>Research.com<br />
http://www.syndicatemarketresearch.com/
<strong>Antidiabetics</strong> <strong>Market</strong><br />
Diabetes mellitus, commonly known as diabetes, is a group of metabolic diseases in<br />
which blood sugar levels goes extremely high over a prolonged period. <strong>Antidiabetics</strong> are<br />
the medicines developed to stabilize and control blood glucose (sugar) levels amongst<br />
diabetes patient. Antidiabetic drugs are generally used to control diabetes. Insulin<br />
pramlintide (Amylin), GLP-1 receptor agonists such as byetta and victoza are the<br />
different types of antidiabetics drugs. The global antidiabetics market is driven by<br />
increasing prevalence of diabetes mellitus.<br />
Get Full report at http://www.syndicatemarketresearch.com/marketanalysis/antidiabetics-market.html<br />
Increasing disposable income has been resulted into significant changes in lifestyle.<br />
This in turn has been resulted into increasing incidences of disorders such as obesity<br />
which may cause the diabetes. This is primarily triggered the demand for antidiabetics.<br />
Additionally, advancement in pharmaceutical sector helps to drive the antidiabetics<br />
market. However, high cost of insulin is expected to be a major restraint of<br />
antidiabetics market. The market size and forecasts in terms of revenue (USD million)<br />
for the period 2015 to 2020, considering 2014 as the base year, have been provided for<br />
this segment of the report. The report also provides the compounded annual growth<br />
rate (% CAGR) for the forecast period 2015 to 2020.<br />
sales@Syndicate<strong>Market</strong>Research.com
<strong>Antidiabetics</strong> <strong>Market</strong><br />
The report provides a comprehensive view on the antidiabetics; we have included a<br />
detailed competitive scenario and product portfolio of key vendors. To understand the<br />
competitive landscape in the market, an analysis of Porter’s Five Forces model for the<br />
antidiabetics market has also been included. The study encompasses a market<br />
attractiveness analysis, wherein product segments are benchmarked based on their<br />
market size, growth rate and general attractiveness.<br />
Get free sample report at http://www.syndicatemarketresearch.com/requestfor-sample.html?flag=S&repid=51861<br />
The global antidiabetics market is segmented on the basis of product and region. The<br />
productsegments of the global antidiabetics market include insulin, rapid acting, long<br />
acting, premixed, premixed analog, short acting, intermediate acting, antidiabetics,<br />
alpha-glucosidase inhibitors, biguanides, sulphonylureas, glp-1 agonist, meglitinides,<br />
dpp-4 inhibitors, sglt – 2 and thiazolodinediones. Insulin dominated the overall market<br />
in terms of revenue.<br />
Major regional segments analyzed in this study include North America, Europe, Asia<br />
Pacific, Latin America, and Middle East & Africa, further bifurcation of region on the<br />
country level, which include U.S., Germany, UK, France, China, Japan and India. North<br />
America dominated antidiabetics market.<br />
Some of the key players for global antidiabetics market include Boehringer Ingelheim<br />
GmbH, Astra Zeneca plc, Eli Lilly & Co., Merck & Co. Inc., Novartis AG, Novo Nordisk<br />
sales@Syndicate<strong>Market</strong>Research.com
<strong>Antidiabetics</strong> <strong>Market</strong><br />
A/S, SanofiS.A., Johnson & Johnson, Mankind Pharma Ltd., and Teva Pharmaceutical<br />
Industries Ltd.<br />
Get free sample report at http://www.syndicatemarketresearch.com/requestfor-sample.html?flag=S&repid=51861<br />
Key segments of the Global <strong>Antidiabetics</strong> <strong>Market</strong><br />
Global <strong>Antidiabetics</strong> <strong>Market</strong>: Product Segment Analysis<br />
• Insulin<br />
• Rapid acting<br />
• Long acting<br />
• Premixed<br />
• Premixed analog<br />
• Short acting<br />
• Intermediate acting<br />
• <strong>Antidiabetics</strong><br />
• Alpha-glucosidase inhibitors<br />
• Biguanides<br />
• Sulphonylureas<br />
• GLP-1 agonist<br />
sales@Syndicate<strong>Market</strong>Research.com
<strong>Antidiabetics</strong> <strong>Market</strong><br />
• Meglitinides<br />
• DPP-4 inhibitors<br />
• SGLT – 2<br />
• Thiazolodinediones<br />
Global <strong>Antidiabetics</strong> <strong>Market</strong>: Region Segment Analysis<br />
Get free sample report at http://www.syndicatemarketresearch.com/requestfor-sample.html?flag=S&repid=51861<br />
• North America<br />
• U.S.<br />
• Europe<br />
• UK<br />
• France<br />
• Germany<br />
• Asia-Pacific<br />
• China<br />
• Japan<br />
• India<br />
sales@Syndicate<strong>Market</strong>Research.com
<strong>Antidiabetics</strong> <strong>Market</strong><br />
• Latin America<br />
• Brazil<br />
• Middle East & Africa<br />
Syndicate market research<br />
Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
Email: sales@Syndicate<strong>Market</strong>Research.com<br />
Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Web:http://www.syndicatemarketresearch.com/<br />
sales@Syndicate<strong>Market</strong>Research.com
Change language